Drug intelligence / Profile preview

withania coagulans

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Withania coagulans is a medicinal plant, traditionally used in Ayurveda and other traditional medicine systems for its antidiabetic, anti-inflammatory, antioxidant, wound healing, hepatoprotective, and antimicrobial properties[3][4][5]. The plant contains a number of bioactive compounds, most notably the steroidal lactones known as withanolides (including withaferin A, coagulansol, withanolide A, coagulin, and others), as well as flavonoids, tannins, β-sterols, fatty acids, and aromatic esters[3][4][5]. Extracts of the plant have demonstrated hypoglycemic, antioxidant, immunomodulatory, and anti-inflammatory effects in animal models[1][2], and have shown potential for reducing oxidative stress and pro-inflammatory cytokines (e.g., IL-1β, IL-6, TNF-α) in diabetic kidney injury[2]. Withania coagulans extract also accelerates wound healing by promoting tissue regeneration, collagen synthesis, and angiogenesis[1][3]. The mechanism of action is not fully established but may involve modulation of neurotransmitter systems (e.g., GABAergic activity for anticonvulsant effects), amelioration of oxidative stress, and reduction of inflammatory cytokines[2][3]. Withania coagulans is primarily used as a dietary supplement and herbal medicine, not as a modern pharmaceutical[3][4][5].

Other names
Withania coagulans DunalIndian rennetpaneer dodi
02

Targets

Sucrase-IsomaltaseCOXTYR (Tyrosinase)ButyrylcholinesteraseAcetylcholinesterase15-LOX (Lysyl Oxidase)

Beyond the preview

Go deeper on withania coagulans.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on withania coagulans.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call